[HTML][HTML] Fabrication of active targeting lipid nanoparticles: Challenges and perspectives
Targeted drug and gene delivery is the key for precision therapy. Lipid nanoparticles as non-
viral vectors have attracted extensive attentions in treating a variety of diseases, such as …
viral vectors have attracted extensive attentions in treating a variety of diseases, such as …
Aptamer-functionalized liposomes for targeted cancer therapy
SA Moosavian, P Kesharwani, V Singh… - … Nanocarriers for Cancer …, 2023 - Elsevier
Liposomes are among the most well-documented drug delivery systems in anticancer
therapy owing to their passive targeting capacities besides inherent biocompatibility and …
therapy owing to their passive targeting capacities besides inherent biocompatibility and …
A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumors
RA Paun, S Jurchuk, M Tabrizian - … & Translational Medicine, 2024 - Wiley Online Library
Lipid nanoparticles (LNPs) are biocompatible drug delivery systems that have found
numerous applications in medicine. Their versatile nature enables the encapsulation and …
numerous applications in medicine. Their versatile nature enables the encapsulation and …
siRNA and targeted delivery systems in breast cancer therapy
Recently, nucleic acid drugs have been considered as promising candidates in treatment of
various diseases, especially cancer. Because of developing resistance to conventional …
various diseases, especially cancer. Because of developing resistance to conventional …
Clinical use and future perspective of aptamers
Aptamers are a unique class of nucleic acid molecules currently being investigated for
clinical applications. Aptamers are functional single-stranded oligonucleotides able to form …
clinical applications. Aptamers are functional single-stranded oligonucleotides able to form …
Activation of cancer immunotherapy by nanomedicine
L Wang, H Xu, L Weng, J Sun, Y Jin… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the most difficult diseases to be treated in the world. Immunotherapy has
made great strides in cancer treatment in recent years, and several tumor immunotherapy …
made great strides in cancer treatment in recent years, and several tumor immunotherapy …
Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective
P Bertrand - Journal of Medicinal Chemistry, 2023 - ACS Publications
Aptamers have emerged in recent years as alternatives to antibodies or small molecules to
interfere with the immune check points by blocking the PD-1/PD-L1 interactions and …
interfere with the immune check points by blocking the PD-1/PD-L1 interactions and …
Cancer immunotherapy via nucleic acid aptamers
F Zahedipour, M Majeed, P Kesharwani… - … Nanocarriers for Cancer …, 2023 - Elsevier
Immunotherapy has transformed cancer care in the last decade. Aptamers are single-
stranded RNA or DNA oligonucleotides having three-dimensional folding structures …
stranded RNA or DNA oligonucleotides having three-dimensional folding structures …
Aptamer-based immune drug systems (AptIDCs) potentiating cancer immunotherapy
H Xiong, L Liu, X Liu, H Jiang, X Wang - Chemistry, 2023 - mdpi.com
Aptamers are artificial oligonucleotides with excellent molecule-targeting ability. Compared
with monoclonal antibodies, aptamers have the advantages of low cost, no batch effect, and …
with monoclonal antibodies, aptamers have the advantages of low cost, no batch effect, and …
[HTML][HTML] Potential of Lipid Based Nanodrug Carriers for Targeted Treatment of Glioblastoma: Recent Progress and Challenges Ahead
Malignant brain tumor at its fourth stage (glioblastoma) is the most dangerous and an
unsolved medical challenge till today. Present therapeutic strategies including chemo …
unsolved medical challenge till today. Present therapeutic strategies including chemo …